110 related articles for article (PubMed ID: 6858624)
1. Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
Acta Obstet Gynecol Scand; 1983; 62(1):49-53. PubMed ID: 6858624
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous estrogen therapy. Endometrial response and metabolic effects.
Holst J
Acta Obstet Gynecol Scand Suppl; 1983; 115():1-30. PubMed ID: 6574685
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
Strecker JR; Lauritzen C; Goessens L
Maturitas; 1979 Feb; 1(3):183-90. PubMed ID: 228157
[TBL] [Abstract][Full Text] [Related]
4. 17 beta-estradiol for postmenopausal estrogen replacement therapy.
Nichols KC; Schenkel L; Benson H
Obstet Gynecol Surv; 1984 Apr; 39(4):230-45. PubMed ID: 6717863
[TBL] [Abstract][Full Text] [Related]
5. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
Mattsson LA; Abrahamsson L; Cullberg G; Samsioe G
Arch Gynecol; 1983; 233(2):101-7. PubMed ID: 6683955
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Sipinen S; Lähteenmäki P; Luukkainen T
Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
Helgason S
Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
[TBL] [Abstract][Full Text] [Related]
9. Serum estrogen levels after topic application of estradiol-17 beta on two different cutaneous areas.
Holst J; Carlström K; von Schoultz B
Acta Obstet Gynecol Scand; 1987; 66(2):151-2. PubMed ID: 3618139
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
Powers MS; Schenkel L; Darley PE; Good WR; Balestra JC; Place VA
Am J Obstet Gynecol; 1985 Aug; 152(8):1099-106. PubMed ID: 2992279
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
Brennan JJ; Lu Z; Whitman M; Stafiniak P; van der Hoop RG
Ther Drug Monit; 2001 Apr; 23(2):134-8. PubMed ID: 11294513
[TBL] [Abstract][Full Text] [Related]
12. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.
Hassager C; Riis BJ; Strøm V; Guyene TT; Christiansen C
Circulation; 1987 Oct; 76(4):753-8. PubMed ID: 3308164
[TBL] [Abstract][Full Text] [Related]
13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
[TBL] [Abstract][Full Text] [Related]
15. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
Jensen J; Christiansen C
Am J Obstet Gynecol; 1988 Oct; 159(4):820-5. PubMed ID: 2972209
[TBL] [Abstract][Full Text] [Related]
16. [Influence of the oral adminsitration of estrogens on serum gonadotropins and prolactin after the menopause].
Delvoye P; Vekemans M; Calaf J; L'Hermite M; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):357-9. PubMed ID: 4681545
[No Abstract] [Full Text] [Related]
17. A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy.
Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
Br J Obstet Gynaecol; 1983 Apr; 90(4):355-60. PubMed ID: 6682335
[TBL] [Abstract][Full Text] [Related]
18. Endocrine impact of pure estradiol replacement in postmenopausal women: alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations.
Veldhuis JD; Samojlik E; Evans WS; Rogol AD; Ridgeway CE; Crowley WF; Kolp L; Checinska E; Kirschner MA; Thorner MO
Am J Obstet Gynecol; 1986 Aug; 155(2):334-9. PubMed ID: 3740150
[TBL] [Abstract][Full Text] [Related]
19. Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects.
Lagrelius A; Carlström K; Lunell NO
Acta Obstet Gynecol Scand; 1981; 60(1):33-8. PubMed ID: 6452019
[TBL] [Abstract][Full Text] [Related]
20. Serum estrogens and gonadotropins in developing androgenized and normal female rats.
Cheng HC; Johnson DC
Neuroendocrinology; 1974; 13(6):357-65. PubMed ID: 4858309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
